Flow-injection chemiluminescence and electrogenerated chemiluminescence determination of escitalopram oxalate in tablet form

Luminescence

Volumn 28, Issue 1, 2013, Pages 84-92

  Alarfaj, Nawal A ^a   Aly, Fatma A ^a   Al Qahtany, Abeer A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

cerium(IV); escitalopram oxalate; flow injection chemiluminescence; flow injection electrogenerated chemiluminescence; tablets; tris(2,2' bipyridyl) ruthenium(II)

Indexed keywords

CHEMILUMINESCENCE; OXALIC ACID; RUTHENIUM COMPOUNDS;

BIPYRIDYL; CHEMILUMINESCENCE REACTIONS; ELECTROGENERATED CHEMILUMINESCENCE; ESCITALOPRAM OXALATE; FLOW INJECTION; FLOW INJECTION CHEMILUMINESCENCE; FLOW-INJECTION ELECTROGENERATED CHEMILUMINESCENCE; LIMIT OF DETECTION; TABLET; TRIS(2,2'-BIPYRIDYL) RUTHENIUM(II);

CERIUM COMPOUNDS;

CITALOPRAM; OXALIC ACID DERIVATIVE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; EQUIPMENT; EVALUATION; FLOW INJECTION ANALYSIS; LUMINESCENCE; METHODOLOGY; TABLET;

CITALOPRAM; FLOW INJECTION ANALYSIS; LUMINESCENT MEASUREMENTS; OXALATES; SEROTONIN UPTAKE INHIBITORS; TABLETS;

MLCS; MLOWN;

EID: 84873473711     PISSN: 15227235     EISSN: 15227243     Source Type: Journal    
DOI: 10.1002/bio.2372     Document Type: Article

References (33)

1. http://www.rxlist.com/lexapro-drug.htm. Accessed on 2011.
2. Vetrichelvan T, Arul K, Sumitha M, Umadevi B,. Colorimetric method for the estimation of escitalopram oxalate in tablet dosage form. Indian J Pharm Sci 2010; 72: 269-1.
3. Gandhi SV, Dhavale ND, Jadhav VY, Sabnis SS,. Spectrophotometric and reversed-phase high-performance liquid chromatographic methods for simultaneous determination of escitalopram oxalate and clonazepam in combined tablet dosage form. J AOAC Int 2008; 91: 33-3.
4. Fatema K, Rahman MZ, Biswas SK, Akter S,. Development of UV spectroscopic method for nefopam and escitalopram as INN drugs tablet dosage forms. J Pharm Sci 2010; 3: 4-10.
5. Kakde RB, Satone DD,. Spectrophotometric method for simultaneous estimation of escitalopram oxalate and clonazepam in tablet dosage form. Indian J Pharm Sci 2009; 71: 702-5.
6. Sharm S, Rajpurohit H, Bhandari A, Choudhary VR, Jain TJ,. Zero order spectrophotometric method for estimation of escitalopram oxalate in tablet formulations. Young Pharm 2010; 2: 420-3.
7. Serebruany V, Malinin L, Dragan A, Atar V, Zyle DL, Dragan Ai,. Fluorimetric quantitation of citalopram and escitalopram in plasma: developing an express method to monitor compliance in clinical trials. Clin Chem Lab Med 2007; 45: 513-20.
8. Taha EA, Salama N, Wang NS,. Micelle enhanced fluorimetric and thin layer chromatography densitometric methods for the determination of (+/-) citalopram and its S-enantiomer escitalopram. Anal Chem Insights 2009; 4: 1-9.
9. Dhavale N, Gandhi S, Sabnis S, Bothara K,. Simultaneous HPTLC Determination of Escitalopram Oxalate and Clonazepam in Combined Tablets. Chromatographia 2008; 67: 487-90.
10. Mahadik MV, Dhaneshwar SR, Kulkarni MJ,. Application of stability indicating HPTLC method for quantitative determination of escitalopram oxalate in pharmaceutical dosage form Eurasian. J Anal Chem 2007; 2: 101-17.
11. Greiner C, Hiemke C, Bader W, Haen E,. Determination of citalopram and escitalopram together with their active main metabolites desmethyl(es-) citalopram in human serum by column-switching high performance liquid chromatography (HPLC) and spectrophotometric detection. J Chromatogr B 2007; 848: 391-4.
12. Syama SB, Suneetha A,. Development and validation of liquid chromatographic method for escitalopram oxalate in tablet dosage forms. Int J Pharm Bio Sci 2011; 2: 140-6.
13. Dhaneshwar SR, Mahadik MV, Kulkarni MJ,. Column liquid chromatography-ultraviolet and column liquid chromatography/mass spectrometry evaluation of stress degradation behavior of escitalopram oxalate. J AOAC Int 2009; 92: 138-47.
14. Singh SS, Shah H, Gupta S, Jain M, Sharma K, Thakkar P, Shab R,. Liquid chromatography - electrospray ionisation mass spectrometry method for the determination of escitalopram in human plasma and its application in bioequivalence study. J Chromatogr B 2004; 811: 209-15.
15. Frison G, Favretto D, Vogliardi S, Terranova C, Ferrara S,. Quantification of citalopram or escitalopram and their demethylated metabolites in neonatal hair samples by liquid chromatography-tandem mass spectrometry. Ther Drug Monit 2008; 30: 467-73.
16. Sungthong B, Jac P, Scriba GK,. Development and validation of a capillary electrophoresis method for the simultaneous determination of impurities of escitalopram including the R-enantiomer. J Pharm Biomed Anal 2008; 46: 959-65.
17. Garcia-Campana AM,., Baeyens WR,. Chemiluminescence in Analytical Chemistry. Marcel Dekker: New York, 2001.
18. Gerardi RD, Barnett NW, Lewis SW,. Analytical applications of tris(2,2'-bipyridyl)ruthenium(III) as a chemiluminscent reagent. Anal Chim Acta 1999; 378: 1-41.
19. Lee WY,. Tris (2,2'-bipyridyl)ruthenium(II) electrogenerated chemiluminescence in analytical science. Mikrochim Acta 1997; 127: 19-39.
20. Calokerinos AC, Deftereos NT, Baeyens WR,. Chemiluminescence in drug assay. J Pharm Biomed Anal 1995; 13: 1063-71.
21. Bowie AR, Sanders MG, Worsfold PJ,. Analytical applications of liquid phase chemiluminescence reactions - a review. Luminescence 1996; 11: 61-90.
22. Aly FA, Alarfaj NA, Warthan AA,. Flow-injection chemiluminescence determination of some phenothiazines in dosage forms and biological fluids. Anal Chim Acta 1998; 358: 255-62.
23. Alarfaj NA,. Flow-injection chemiluminescence determination of enalapril maleate in pharmaceuticals and biological fluids using tris(2,2'-bipyridyl) ruthenium(II). Anal Sci 2003; 19: 1145-49.
24. 2+-permanganate system. Talanta 2004; 62: 255-63.
25. Barnett NW, Bowser TA, Russell AA,. Determination of oxalate in Alumina Process Liquors by Ion chromatography with post column chemiluminescence detection. Anal Proc 1995; 32: 57-9.
26. Barnett NW, Bowser TA, Gerardi R, Smith DB,. Determination of codeine in process streems using flow-injection analysis with chemiluminescence detection. Anal Chim Acta 1996; 318: 309-17.
27. Han H, He Z, Zeng Y,. Chemiluminescence determination of tetracyclines using a tris(2,2'-bipyridine)ruthenium(II) and potassium permanganate system. Anal Sci 1999; 15: 467-70.
28. 2+. J Am Chem Soc 1981; 103: 512-6.
29. Juris A, Barigelletti F, Campagna S, Balzani V, Belser P, von Zelewsky A,. Ruthenium(II)-polypyridine complexes: photophysics, photochemistry, electrochemistry, and chemiluminescence. Coord Chem Rev 1988; 84: 85-277.
30. Miller JN, Miller JC,. Statistics and Hemometrics for Analytical Chemistry, 5th edn. Pearson Prentice Hall: England, 2005.
31. International Conference on Harmonization, ICH Harmonised Tripartite Guideline, Q2(R1), Validation of analytical Procedures: Text and Methodology, Switzerland, 1995.
32. Greenway GM, Dolman SJ,. Analysis of tricyclic antidepressants using electrogenerated chemiluminescence. Analyst 1999; 124: 759-62.
33. Greenway GM, Knight PJ,. Determination of oxprenolol by electrogenerated chemiluminescence. Anal Proc 1995; 32: 251-3.